Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-12-18 00:00:00 ET · period of report 2024-12-17 · accession 0001674236-24-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-18 | 2024-12-17 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale | $55.79 | -7,500 | 154.5K | -5% | -$418.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-17 | S | D | 7,500 | $55.79 | 154,468 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $55.29 to $56.30. The price reported above reflects the weighted average sales price. |